BioWorld Covers LexaGene’s Pathogen Detection

by LexaGene | Feb 3, 2021 | Biothreat Detection

Home » Biothreat Detection » BioWorld Covers LexaGene’s Pathogen Detection

LexaGene covered in BioWorld on the MiQLab’s ability to detect new variants of pathogens at point-of-care.

Read the Full Article Here

LexaGene

LexaGene develops fully automated, rapid molecular testing at the point-of-need for accurate pathogen detection in human clinical diagnostics, veterinary diagnostics, food safety, and other markets.

Survey Says Veterinarians Have an Appetite for In-Clinic Diagnostic Technology

This spring LexaGene conducted a market research survey in conjunction with AAHA to assess the opinions of practicing veterinarians on AMR stewardship and the use of antibiotics in the treatment of companion animals.

The Dawn of the Superbugs

The most menacing of all resistant bacteria are the so called “super bugs”- strains of bacteria that are resistant to several different classes of antibiotics or multidrug resistant.

LexaGene offers North Shore Technology Council (NSTC) and Leadership Team at MassBio a tour of our Beverly Facility

Recently, we welcomed members of North Shore Technology Council and MassBio Leadership Teams into our facility at 500 Cummings Center for a full tour of our office space and laboratory spaces.

Subscribe for Updates

Upcoming Events

No events in this category to show at this time.

See All Events

Latest Resources

MiQLab for Rapid Response to Novel Biothreats

Biothreat Detection

LexaGene’s MiQLab™ System, a TRL-7 technology, drastically shortens the time gap between novel pathogen identification and point-of-need testing through its open-access feature.

See All Resources